Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle Invasive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02657486
What this trial is testing

BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

Who this might be right for
Bladder CancerNon-Muscle-Invasive Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center 4
Testing effectiveness (Phase 2)Ended earlyNCT04871529
What this trial is testing

Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

Who this might be right for
Bladder Carcinoma Infiltrating the Muscle of the Bladder WallInfiltrating Renal Pelvis and Ureter Urothelial CarcinomaStage II Bladder Cancer AJCC v8
SWOG Cancer Research Network 6
Not applicableUnknownNCT04698551
What this trial is testing

NIPD on cffDNA for Triplet Repeat Diseases

Who this might be right for
Myotonic Dystrophy 1Huntington DiseaseFragile X Syndrome
University Hospital, Montpellier 36
Not applicableActive Not RecruitingNCT07172529
What this trial is testing

Pulmonary Function, Muscle Strength, and Functional Capacity in Minimally Invasive Cardiac Surgery

Who this might be right for
Cardiac SurgeryMuscle Weakness | PatientPulmonary Function+1 more
Zehra Can Karahan 40
Not applicableNot Yet RecruitingNCT07749924
What this trial is testing

Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC

Who this might be right for
Bladder CancerNon-Muscle-Invasive Bladder Cancer (NMIBC)
Tianjin Medical University Second Hospital 670
Testing effectiveness (Phase 2)Looking for participantsNCT07420517
What this trial is testing

Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Paul Toren 95
Testing effectiveness (Phase 2)UnknownNCT05495724
What this trial is testing

Disitamab Vedotin Combined With Tislelizumab for Her2 Overexpressing High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable

Who this might be right for
Her2 Overexpressing High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
Tianjin Medical University Second Hospital 176
Not applicableUnknownNCT05236218
What this trial is testing

To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).

Who this might be right for
Muscle Invasive Bladder CancerSurgerySexual Wellbeing+2 more
King's College London 60
Testing effectiveness (Phase 2)Ended earlyNCT00268450
What this trial is testing

Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery

Who this might be right for
Bladder Cancer
Medical University of South Carolina 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07445308
What this trial is testing

The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With NMIBC, and to Determine the RP2D of SPGL008 Alone or in Combination With BCG.To Evaluate the Preliminary Efficacy of SPGL008 Alone or in Combination With BCG.

Who this might be right for
NMIBC
Shenyang Sunshine Pharmaceutical Co., LTD. 120
Early research (Phase 1)WithdrawnNCT04073160
What this trial is testing

TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Daniel George, MD
Early research (Phase 1)WithdrawnNCT02863913
What this trial is testing

PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder Cancer

Who this might be right for
Invasive Bladder Cancer Stage IV
Peking University
Large-scale testing (Phase 3)Looking for participantsNCT07720284
What this trial is testing

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Who this might be right for
High-risk Muscle Invasive Urothelial Carcinoma
AstraZeneca 915
Large-scale testing (Phase 3)UnknownNCT01225614
What this trial is testing

Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive

Who this might be right for
MyopathyMuscular WeaknessRespiratory Insufficiency
Assistance Publique - Hôpitaux de Paris 77
Large-scale testing (Phase 3)Active Not RecruitingNCT02951325
What this trial is testing

Bladder Cancer Adjuvant Radiotherapy Trial

Who this might be right for
Bladder CancerUrothelial Carcinoma Bladder
Tata Memorial Centre 153
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07356791
What this trial is testing

Phase II Prospective Cohort Study of Intravesical Recombinant Human Type 5 Adenovirus Injection for Treatment of High-Risk Non-Muscle Invasive Bladder Cancer: Evaluating Efficacy and Safety

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
RenJi Hospital 18
Testing effectiveness (Phase 2)WithdrawnNCT02845050
What this trial is testing

Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO)

Who this might be right for
Bladder Cancer
Ligartis GmbH
Testing effectiveness (Phase 2)Looking for participantsNCT07647289
What this trial is testing

EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)
Peking University Third Hospital 58
Not applicableLooking for participantsNCT06092450
What this trial is testing

Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
First Affiliated Hospital of Chongqing Medical University 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT03978624
What this trial is testing

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

Who this might be right for
Bladder Cancer
UNC Lineberger Comprehensive Cancer Center 20
Next Page